March 7, 2013
ABC news highlights hearing loss as a growing trend in society and the impact of using earbuds at high volume. Watch this informative video with lead reporter Diane Sawyer... Watch now ...

December 5, 2012
Sound Pharmaceuticals and the University of Florida begin enrollment on a Phase II study with SPI-1005 to prevent and treat noise induced hearing loss…Read More...

November 28, 2012
Nobel Prize Winner Bruce Beutler joins Sound Pharmaceuticals Scientific Advisory Board...Read More...

November 13, 2012
SPI granted patent for prevention and treatment of side effects of chemotherapy...Read more…

May 4, 2012
SPI in Nature Medicine’s “Sound Medicine” News Feature…Read More...

February 9, 2012
Seattle’s King5TV shows story on noise induced hearing loss and SPI-1005…Read More and Watch Video...

February 2, 2012
Tampa FoxTV runs story on SPI-1005 to prevent hearing loss…Read More and Watch Video...

November 29, 2011
UF researchers to evaluate SPI-1005 in iPod clinical trial…Read More...

September 6, 2011
Bioworld Insight coverage on hearing loss R&D... Read More (Pg. 2)...

June 6, 2011
Sound Pharma announces a new otoprotection clinical trial involving personal music players… Read more...

February 24, 2011
UCLA and Sound Pharmaceuticals identify a key hearing regeneration protein in the human inner ear... Read More...

November 1, 2010
Sound Pharma receives grants from the IRS under the Qualifying Therapeutic Discovery Project program created by the Patient Protection and Affordable Care Act of 2010... Read More...

September 15, 2010
Sound Pharma to receive $3M in DoD funding to further develop our hearing regeneration program through Sen. Patty Murray’s recommendation and support… Read More...

June 8, 2010
Sound Pharma’s otoprotection and regeneration work were presented at the Office of Naval Research Conference on Noise Induced Hearing Loss in San Diego, CA. ONR commissioned a video demonstrating some of its externally funded research efforts in NIHL…View Video...

August 19, 2009
SPI receives Office of Naval Research award for hearing loss research and development. Read more...

November 12, 2008
SPI awarded best presentation at the 16th Annual AMSCON/AMSUS meeting for it's clinical otoprotection work. Read more about AMSUS...

October 30, 2008
SPI invited to be a speaker at GTCBio's CNS Diseases Partnering and Deal-Making Summit.
See Current Conferences by GTCBio...

August 7, 2008
FDA Allows Phase 2 Study for Sound Pharmaceuticals' Novel Drug to Prevent Chemotherapy Induced Hearing Loss. Read More...

July 23, 2008
Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer. Read More...

July 21, 2008
Sound Pharmaceuticals Receives Additional DoD Funding for Its Hearing Regeneration Product. Read More...

March 25, 2008
VentureWire Lifesciences story covers Sound Pharma's start of Ph-II clinical trials of SPI-1005 to prevent and treat noise induced hearing loss. Read more...

August 31, 2007
Neurotech Insights newsletter focuses on Hearing Loss and current R & D efforts of SPI (pg.14)...
Read More...

July 1, 2007
LA Times article on Otoprotection. Read More...

January 4, 2007
Sound Pharmaceuticals Announces the Successful Completion of its Phase I Clinical Trial for SPI-1005.
Read More...

October 13, 2006
Sound Pharmaceuticals supports the formation of the Neurotechnology Industry Organization (NIO) as a founding member. Read more...

July 7, 2006
USPTO issues Notice of Allowance for Novel Patent on Hair Cell Regeneration in the Inner Ear.
Read More...

June 21, 2006
Sound Pharmaceuticals interviewed by MIT Technology Review. Read more…

June 12, 2006
New Drug for Hearing Loss Enters Clinical Testing. Read More...

March 21, 2006
Sound Pharmaceuticals presents at Invest Northwest Life Sciences Conference.
Read More...